Donor cardiac troponin-I: a biochemical surrogate of heart function

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 2, 2009, Pages 286-292

  Venkateswaran, Rajamiyer V ^a   Ganesh, Jegatheesan Saravana ^a   Thekkudan, Joyce ^a   Steeds, Richard ^a   Wilson, Ian C ^a   Mascaro, Jorge ^a   Thompson, Richard ^a   Bonser, Robert Stuart ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cardiac troponin I; Donor management; Heart transplantation

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN I;

ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DONOR; DONOR SELECTION; ENZYME BLOOD LEVEL; FEMALE; HEART CATHETERIZATION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HORMONAL THERAPY; HUMAN; LUNG WEDGE PRESSURE; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWAN GANZ CATHETER; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; BIOLOGICAL MARKERS; CARDIAC OUTPUT; FEMALE; HEART FUNCTION TESTS; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TREATMENT OUTCOME; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 67650074731     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.02.031     Document Type: Article

References (25)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Aurora P., Christie J., Dobbels F., Rahmel A.O., Keck B.M., and Hertz M.I. Registry of the international society for heart and lung transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
2. Wood K.E., Becker B.N., McCartney J.G., D'Alessandro A.M., and Coursin D.B. Care of the potential organ donor. N Engl J Med 351 (2004) 2730-2739
3. Birks E.J., Burton P.B., Owen V., Mullen A.J., Hunt D., Banner N.R., Barton P.J., and Yacoub M.H. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 (2000) 352-358
4. Birks E.J., Owen V.J., Burton P.B., Bishop A.E., Banner N.R., Khaghani A., Polak J.M., and Yacoub M.H. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 102 (2000) 326-331
5. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
6. Riou B., Dreux S., Roche S., Arthaud M., Goarin J.P., Leger P., Saada M., and Viars P. Circulating cardiac troponin T in potential heart transplant donors. Circulation 92 (1995) 409-414
7. Potapov E.V., Ivanitskaia E.A., Loebe M., Mockel M., Muller C., Sodian R., Meyer R., and Hetzer R. Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 71 (2001) 1394-1400
8. Potapov E.V., Wagner F.D., Loebe M., Ivanitskaia E.A., Muller C., Sodian R., Jonitz B., and Hetzer R. Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol 92 (2003) 163-167
9. Vijay P., Scavo V.A., Morelock R.J., Sharp T.G., and Brown J.W. Donor cardiac troponin T: a marker to predict heart transplant rejection. Ann Thorac Surg 66 (1998) 1934-1939
10. Anderson J.R., Hossein-Nia M., Brown P., Holt D.W., and Murday A. Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation. Transplantation 58 (1994) 1056-1057
11. Deibert E., Aiyagari V., and Diringer M.N. Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation. Heart 84 (2000) 205-207
12. Khush K.K., Menza R.L., Babcock W.D., and Zaroff J.G. Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation. J Heart Lung Transplant 26 (2007) 1048-1053
13. Boccheciampe N., Audibert G., Rangeard O., Carpentier C., Perrier J.F., Lalot J.M., Voltz C., Strub P., Loos-Ayav C., Meistelman C., Mertes P.M., and Longrois D. Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients. Int J Cardiol 133 (2009) 80-86
14. Venkateswaran R.V., Patchell V.B., Wilson I.C., Mascaro J.G., Thompson R.D., Quinn D.W., Stockley R.A., Coote J.H., and Bonser R.S. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 85 (2008) 278-286
15. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., and Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function-a study in normals and dilated cardiomyopathy. J Cardiol 26 (1995) 357-366
16. Potter C.D., Wheeldon D.R., and Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant 14 (1995) 59-65
17. Adams III J.E., Bodor G.S., Davila-Roman V.G., Delmez J.A., Apple F.S., Ladenson J.H., and Jaffe A.S. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993) 101-106
18. Katus H.A., Remppis A., Looser S., Hallermeier K., Scheffold T., and Kubler W. Enzyme linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 21 (1989) 1349-1353
19. Darracott-Cankovic S., Stovin P.G., Wheeldon D., Wallwork J., Wells F., and English T.A. Effect of donor heart damage on survival after transplantation. Eur J Cardiothorac Surg 3 (1989) 525-532
20. Naidech A.M., Kreiter K.T., Janjua N., Ostapkovich N.D., Parra A., Commichau C., Fitzsimmons B.F., Connolly E.S., and Mayer S.A. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation 112 (2005) 2851-2856
21. Zaroff J.G., Rordorf G.A., Ogilvy C.S., and Picard M.H. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 13 (2000) 774-779
22. Zaroff J.G., Babcock W.D., Shiboski S.C., Solinger L.L., and Rosengard B.R. Temporal changes in left ventricular systolic function in heart donors: results of serial echocardiography. J Heart Lung Transplant 22 (2003) 383-388
23. Deibert E., Barzilai B., Braverman A.C., Edwards D.F., Aiyagari V., Dacey R., and Diringer M. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg 98 (2003) 741-746
24. Banki N.M., Kopelnik A., Dae M.W., Miss J., Tung P., Lawton M.T., Drew B.J., Foster E., Smith W., Parmley W.W., and Zaroff J.G. Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 112 (2005) 3314-3319
25. Mertes P.M., Carteaux J.P., Jaboin Y., Pinelli G., el Abassi K., Dopff C., Atkinson J., Villemot J.P., Burlet C., and Boulange M. Estimation of myocardial interstitial norepinephrine release after brain death using cardiac microdialysis. Transplantation 57 (1994) 371-377